Buerke U, Pruefer D, Carter J M, Russ M, Schlitt A, Prondzinsky R, Makowski J, Rohrbach S, Niemann B, Schulze C, Dahm M, Vahl C-F, Werdan K, Buerke M
Department of Internal Medicine III, Martin Luther-University, Halle Saale, Germany.
Br J Pharmacol. 2008 Apr;153(8):1678-85. doi: 10.1038/sj.bjp.0707647. Epub 2008 Mar 10.
The Na(+)/H(+) exchange (NHE) inhibitor cariporide is known to ameliorate ischaemia/reperfusion (I/R) injury by reduction of cytosolic Ca(2+) overload. Leukocyte activation and infiltration also mediates I/R injury but whether cariporide reduces I/R injury by affecting leukocyte activation is unknown. We studied the effect of cariporide on thrombin and I/R induced leukocyte activation and infiltration models and examined P-selectin expression as a potential mechanism for any identified effects.
An in vivo rat mesenteric microcirculation microscopy model was used with stimulation by thrombin (0.5 micro ml(-1)) superfusion or ischaemia (by haemorrhagic shock for 60 min) and reperfusion (90 min).
Treatment with cariporide (10 mg kg(-1) i.v.) significantly reduced leukocyte rolling, adhesion and extravasation after thrombin exposure. Similarly, cariporide reduced leukocyte rolling (54+/-6.2 to 2.4+/-1.0 cells min(-1), P<0.01), adherence (6.3+/-1.9 to 1.2+/-0.4 cells 100 microm(-1), P<0.01) and extravasation (9.1+/-2.1 to 2.4+/-1.1 cells per 20 x 100 microm perivascular space, P<0.05), following haemorrhagic shock induced systemic ischaemia and reperfusion. The cell adhesion molecule P-selectin showed a profound decrease in endothelial expression following cariporide administration in both thrombin and I/R stimulated groups (35.4+/-3.2 vs 14.2+/-4.1% P-selectin positive cells per tissue section, P<0.01).
The NHE inhibitor cariporide is known to limit reperfusion injury by controlling Ca(2+) overload but these data are novel evidence for a vasculoprotective effect of NHE inhibition at all levels of leukocyte activation, an effect which is likely to be mediated at least in part by a reduction of P-selectin expression.
已知钠氢交换体(NHE)抑制剂卡里波罗德可通过减少胞质钙超载来改善缺血/再灌注(I/R)损伤。白细胞活化和浸润也介导I/R损伤,但卡里波罗德是否通过影响白细胞活化来减轻I/R损伤尚不清楚。我们研究了卡里波罗德对凝血酶和I/R诱导的白细胞活化及浸润模型的影响,并检测了P-选择素的表达,将其作为任何已确定效应的潜在机制。
使用体内大鼠肠系膜微循环显微镜模型,通过凝血酶(0.5 μl/ml)灌注或缺血(失血性休克60分钟)及再灌注(90分钟)进行刺激。
给予卡里波罗德(10 mg/kg静脉注射)后,凝血酶刺激后白细胞滚动、黏附和渗出显著减少。同样,在失血性休克诱导的全身缺血及再灌注后,卡里波罗德减少了白细胞滚动(从54±6.2降至2.4±1.0个细胞/分钟,P<0.01)、黏附(从6.3±1.9降至1.2±0.4个细胞/100μm,P<0.01)和渗出(从9.1±2.1降至2.4±1.1个细胞/每20×100μm血管周围间隙,P<0.05)。在凝血酶和I/R刺激组中,给予卡里波罗德后,细胞黏附分子P-选择素在内皮细胞中的表达均显著降低(每个组织切片中P-选择素阳性细胞从35.4±3.2%降至14.2±4.1%,P<0.01)。
已知NHE抑制剂卡里波罗德通过控制钙超载来限制再灌注损伤,但这些数据为NHE抑制在白细胞活化各个水平上的血管保护作用提供了新证据,这种作用可能至少部分是通过降低P-选择素表达介导的。